Bimagrumab
Products Bimagrumab is in clinical development at Novartis and is not currently commercially available. The antibody was developed at MorphoSys in Munich. Structure and properties Bimagrumab is a human monoclonal antibody. Effects Bimagrumab promotes skeletal muscle development. The antibody binds with high affinity to type II activin receptors and prevents the binding of the natural … Bimagrumab
